Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. - Wikidata - wikimedia - TriplyDB

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.

http://www.wikidata.org/entity/Q46689753

about

Brain tumors Potential applications of imaging and image-guided radiotherapy for brain metastases and glioblastoma to improve patient quality of life Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods Emerging methods for disease monitoring in malignant gliomas Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?Functional brain imaging: an evidence-based analysis Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis.MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas.Post-treatment imaging changes in primary brain tumors.Imaging biomarkers in primary brain tumours.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.Diagnostics of cerebral gliomas with radiolabeled amino acids.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.3'-Deoxy-3'-[(18)F]fluorothymidine and O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative Study Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.Pseudoprogression: relevance with respect to treatment of high-grade gliomas.Molecular imaging of gliomas with PET: opportunities and limitations.Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding.High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.Advances in neuro-oncology imaging.Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches.Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.Treatment options for recurrent glioblastoma: pitfalls and future trends.The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies Pseudoprogression after glioma therapy: a comprehensive review.[(18)F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients - A Review.Treating recurrent glioblastoma: an update.Amino acid PET and MR perfusion imaging in brain tumours.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.PET/MRI in cancer patients: first experiences and vision from Copenhagen.Paediatric nuclear medicine imaging.Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.

P2860

Q24605136-E489616E-F650-47A9-95F1-DA0D8FED743D Q26830580-0757B8C2-746F-41FE-97C0-2171D2E73572 Q26853516-DE480062-A91D-4AB7-9041-5C770C2EA1C2 Q27023823-9A36C4BB-A7BD-4619-B767-53C521E7A750 Q30418915-7D92034B-B0BF-4DD4-BE8F-20D94FD13428 Q30573784-3688B549-4071-4A44-B4C3-412E2C2253BB Q30582849-A77773F6-D61D-4A5D-A772-33CB8442325B Q30636257-CF5A527E-3379-4067-A362-F295C9976FC6 Q30835236-0750C5F8-C353-4650-A387-783C42C402B3 Q30880129-EACBB632-FF80-4C15-BC0F-F2BCC164F214 Q30907831-39FF1B29-270B-4F35-8C16-09A51708448D Q33432870-047A87C4-1520-4951-B531-D6431D4C5100 Q33487194-19C5881E-453E-4208-B94A-6943F5706576 Q33578187-88EB4BE1-E857-48FD-8291-B8CEC0F1C082 Q33704202-15CE8DFF-5310-4F7B-8EEE-499A78F12E11 Q33888131-88198DA3-6A7E-45F2-BC1A-2344C7725D5F Q33905441-4B7677DE-9041-4123-9C79-A63F6ECE47C0 Q33961188-5D4EE5FE-69D3-4C2B-A9AA-4452CE768A04 Q34087196-5C212D0B-8108-4E37-B31C-D361FD160F51 Q34620657-B5364329-94BC-4468-9E22-0A95A38959E0 Q35035576-76D8947E-7A7D-4552-9D06-CFA3F4F9AA5A Q36021392-0703EA53-B8AA-423C-A9A3-5B4D514F83B1 Q36107374-57529002-9361-4AE9-A68D-24BAA8931657 Q36339461-06C0EEBD-D253-4E06-B30B-3A337E879AED Q37000245-0AD39012-A8A6-4BC9-B314-1B5E7059F550 Q37182922-E351ACDE-2ECE-4B68-8B20-076760B410BA Q37432387-F67D8A52-6DE2-45FC-BAF4-175E8CCC3570 Q37455074-3653D80F-9012-458F-91E4-66BF5CAEC952 Q37483971-BD7BF0FD-5394-4471-829E-1253F0C107EC Q37614748-388E0453-F461-427E-ABC8-A7F6C366D3B3 Q38074638-1B286160-58E2-46AF-88F8-27889BC8B17F Q38094809-3DB2342D-88AA-4939-9CC7-4671148C7399 Q38102999-536EB81D-C7D6-4CAF-A5A7-D69B40D5C50D Q38376610-F7972E7A-EBFD-41B5-8D38-4306EC4D130C Q38691946-51DE3CCA-455C-4822-B9DD-10AEF2256D43 Q38815396-ECAC8952-9AA1-4F50-87C1-842B87676943 Q38964679-94712976-80B9-40FA-9340-4B712E843228 Q39498230-0878C520-EB4B-4639-8C29-CE3B7F7F9E2A Q40045765-E9D74423-F243-4F62-87E3-224BBA86B3D5 Q41594601-5B22D147-06A2-4067-A90A-624033D7F358

P2860

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.

http://www.wikidata.org/entity/Q46689753

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Positron emission tomography with O-

@nl

Positron emission tomography w ...... iagnosis of recurrent gliomas.

@en

type

label

Positron emission tomography with O-

@nl

Positron emission tomography w ...... iagnosis of recurrent gliomas.

@en

prefLabel

Positron emission tomography with O-

@nl

Positron emission tomography w ...... iagnosis of recurrent gliomas.

@en

P1433

Q46689753-3B59E3AD-B10D-4D78-AB1C-3DED464EC5FA

P1476

Q46689753-CFC17246-E18E-4AB6-8779-CD38DD3028EB

P2093

Q46689753-081C6E81-791E-453A-8D98-BF8712B810E8

Q46689753-619ABC6D-4459-48C4-9690-C8F53856DC0A

Q46689753-62CEEC9C-F501-4D75-8F4D-4286F40838EE

Q46689753-63B9E6EC-DD22-4E4A-88DD-783444C7D1C0

Q46689753-75B09571-8F0B-4D82-AE9C-F2E82413112A

Q46689753-8414CEEE-63FC-4608-9A56-587D9770EBF5

Q46689753-A27958D6-3260-4444-B350-4ADEAB52352C

Q46689753-B5856266-F8E0-48EE-8A6A-0E50819BFD0A

Q46689753-C1E807FC-7F5C-4845-BED6-010406A7CBAB

P304

Q46689753-33321204-7586-4F83-906D-DB4B5A06DD80

P31

Q46689753-0FA418FA-EFFC-4FA4-A387-AF94B328735F

P356

Q46689753-644E657D-8F56-4EA1-8ACF-B98551A15C8C

P407

Q46689753-3FEA546C-FA34-450A-B9EF-BFB4EE610709

P433

Q46689753-3443FF16-1210-407C-B5D7-A183674314A6

P478

Q46689753-7C91D662-06C9-4E74-AFA9-E3A00BC6AF7E

P50

Q46689753-4CD1DD0D-C183-4357-A058-48EE41038922

Q46689753-774C1F87-9B50-48FE-9573-6A57D54B4CE3

Q46689753-7813D8C1-EC2B-4336-AE0E-0BB2C7BE1277

Q46689753-D71CD5E9-F9F0-45DD-B3B5-21F8C49548B6

P577

Q46689753-A6090F4A-FF46-4A67-AC2E-5DCB32F3F3EF

P698

Q46689753-40F091B8-B9AF-44B9-9C8E-39FEA2CD6608

P356

01.NEU.0000171642.49553.B0

P1433

P1476

Positron emission tomography w ...... iagnosis of recurrent gliomas.

@en

P2093

Claudia Goetz

http://www.w3.org/2001/XMLSchema#string

Franz Josef Gildehaus

http://www.w3.org/2001/XMLSchema#string

Friedrich Wilhelm Kreth

http://www.w3.org/2001/XMLSchema#string

Gabriele Pöpperl

http://www.w3.org/2001/XMLSchema#string

Jochen Herms

http://www.w3.org/2001/XMLSchema#string

Klaus Tatsch

http://www.w3.org/2001/XMLSchema#string

Markus Holtmannspötter

http://www.w3.org/2001/XMLSchema#string

Walter Koch

http://www.w3.org/2001/XMLSchema#string

Walter Rachinger

http://www.w3.org/2001/XMLSchema#string

P304

505-11; discussion 505-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1227/01.NEU.0000171642.49553.B0

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Jörg-Christian Tonn

Friedrich-Wilhelm Kreth

Markus Holtmannspötter

Gabriele Pöpperl

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16145529

http://www.w3.org/2001/XMLSchema#string